WITHDRAWN: Anzi Mixture Reduces ACA Levels and Decreases the Embryo Absorption Rate of ACA Positive Abortion Mice via Modulating T-bet/GATA-3 Molecules and Th1/Th2 Cell-associated Cytokines

Title:WITHDRAWN: Anzi Mixture Reduces ACA Levels and Decreases the Embryo Absorption Rate of ACA Positive Abortion Mice via Modulating T-bet/GATA-3 Molecules and Th1/Th2 Cell-associated Cytokines

Volume: 21

Author(s): Hongyu Guo, Qingling Ren, Cong Chen, Jing Qian, Yuqing Zhao and Qibin Lu*

Affiliation:

• Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China

Abstract: Since the authors are not responding to the editor’s requests to fulfill the editorial requirement, therefore, the article has been withdrawn from the journal Letters in Drug Design & Discovery.

Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused.

The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorial-policies-main.php.

BENTHAM SCIENCE DISCLAIMER:

It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.

Cite this article as:

Guo Hongyu, Ren Qingling, Chen Cong, Qian Jing, Zhao Yuqing and Lu Qibin*, WITHDRAWN: Anzi Mixture Reduces ACA Levels and Decreases the Embryo Absorption Rate of ACA Positive Abortion Mice via Modulating T-bet/GATA-3 Molecules and Th1/Th2 Cell-associated Cytokines, Letters in Drug Design & Discovery 2024; 21 () . https://dx.doi.org/10.2174/1570180819666220510121050